Following recent advances in genetic engineering, development of new pharmaceutical
products for the treatment of various diseases, previously difficult to
treat, has been carried out. Research and development are active across the world about the promising
next-generation drugs such as those making use of nucleic acid (nucleic
acid drucs) for gene expression regulation (antisense, decoy, siRNA, etc.),
inhibition of the function for specific target molecules withaptamers,
and so on.
We will continue our efforts for
development of nucleic acid-based new-generation medicines and diagnostic
reagents, with a goal set at becoming an enterprise contributing to human
welfare and health through nucleic acid technology development.